Skip to main content
International Journal of Women's Health logoLink to International Journal of Women's Health
. 2026 Feb 17;18:586732. doi: 10.2147/IJWH.S586732

Preeclampsia Among Pregnant Women Admitted to a Tertiary Care Hospital in Taiz City: Insights from a Conflict-Stricken Setting in Southwest Yemen

Hanan M Hasan 1,, Maisa S M Thabit 2, Maha Abdulaziz 1
PMCID: PMC12927749  PMID: 41736765

Abstract

Background

Preeclampsia (PE) contributes substantially to morbidity and mortality among mothers and newborns, especially in conflict-stricken settings like Yemen, where data are limited. This study investigated the prevalence and factors associated with PE among pregnant women at a tertiary care hospital in Taiz, southwest of Yemen.

Methods

From January to December 2024, a retrospective cross-sectional study was conducted among 205 pregnant women admitted to the Republican General Teaching Hospital in Taiz. Women’s demographics, obstetric characteristics and medical history were extracted from medical records using a data collection sheet. Descriptive statistics were used to summarize data, and chi-square or Fisher’s exact tests were used to assess associations with PE, with P-values <0.05 being considered statistically significant.

Results

PE prevalence was 10.7% (22/205; 95% CI: 6.9–15.8). Gestational age (GA) at admission was significantly associated with PE, where the likelihood of PE was more than 10-fold higher among women admitted at <37 weeks compared to those admitted at ≥37 weeks (OR 10.6; 95% CI: 4.05–27.60; P < 0.001). Although a higher risk of PE was observed among women who were nulliparous, had twin pregnancies, chronic hypertension or a history of PE, these associations were not statistically significant. No significant associations were also found with maternal age, place of residence, gravidity, antenatal care follow-up, abortion history, gestational diabetes, or renal disease.

Conclusion

PE affects approximately one in ten pregnant women admitted for delivery in Taiz, exceeding regional and global estimates. Its significant association with GA <37 weeks indicates the need to improve antenatal screening, early detection, and high-risk pregnancy management to reduce preventable maternal and neonatal complications.

Keywords: preeclampsia, pregnant women, prevalence, associated factors, Yemen

Introduction

Preeclampsia (PE) is a gestational hypertensive disorder that substantially contributes to maternal and perinatal morbidity and mortality worldwide.1 According to the International Society for the Study of Hypertension in Pregnancy (ISSHP), PE is hypertension (HTN) occurring at or beyond 20 weeks of gestation with one or more new-onset conditions, such as proteinuria, end-organ dysfunction (brain, kidney, liver, or hematological), pulmonary edema, or utero-placental dysfunction.2 Likewise, the American College of Obstetricians and Gynecologists (ACOG) defines PE as HTN (systolic ≥140 mmHg or diastolic ≥90 mmHg) with or without proteinuria, in association with features such as thrombocytopenia, renal impairment, liver dysfunction, pulmonary edema, or unexplained headache, typically occurring at or after 20 weeks of gestation.3

The World Health Organization (WHO) estimates that PE affects 2–8% of pregnancies globally.4 According to a recent meta-analysis, the global prevalence of PE was estimated at 4.4% with significant regional variations and a higher prevalence in low-income countries.5 According to recent Global Burden of Disease (GBD) data, the global age-standardized incidence rate of maternal hypertensive disorders has decreased from 554.35 per 100,000 in 1990 to 461.94 per 100,000 in 2021, while the age-standardized death rate declined from 1.94 per 100,000 to 0.97 per 100,000 during the same period.6 Despite these improvements, the burden of disease remains disproportionately high in low-resource settings with limited access to timely and adequate maternal healthcare.6 The WHO estimates that the incidence of PE is seven times greater in developing nations compared to developed nations.7

The prevalence of PE in the Middle East varies substantially both within and across countries, ranging from 0.17% to 5%.8 Regional data about PE from Arab countries remain limited, but published studies report rates of 1% in Lebanon, 1.2–2.3% in Qatar, 1.3–4.7% in Jordan, 1.1–4.2% in Saudi Arabia, 1.9–2.7% in Bahrain, 2.4% in Occupied Palestinian Territory (OPT), Iraq (4.4%).9–19 However, PE was found as a frequent pregnancy complication among 26.1% of renal transplant recipients in five Middle Eastern countries (Lebanon, Saudi Arabia, Syria, Oman, and Turkey).20 The limited availability of epidemiological studies emphasizes the necessity of further research to better characterize the true burden of PE across Arab nations, including Yemen.

Several studies have identified a number of factors that predispose pregnant women to PE, including gestational diabetes mellitus (GDM), chronic HTN, obesity, metabolic syndrome, antiphospholipid syndrome, advanced maternal age, a previous history of PE, nulliparity, chronic kidney disease, multiple gestation, donor-oocyte pregnancies, and the utilization of assisted reproductive technologies.21–25 Understanding these factors is crucial for early detection and management to reduce maternal and neonatal complications. PE is associated with a number of adverse maternal outcomes, including higher rates of cesarean sections, mortality and serious complications such as liver dysfunction/HELLP syndrome, pulmonary edema, stroke, acute kidney injury, postpartum hemorrhage, and intensive care unit admission.12 Additionally, it is associated with several adverse neonatal outcomes such as stillbirth, preterm birth, low birth weight, low Apgar scores, intrauterine growth restriction, and higher rates of neonatal intensive care unit admission.26 These adverse outcomes can be reduced with improved antenatal care (ANC) and early detection, highlighting the need for health education and accessible services for populations at high risk.

High-risk pregnancies, including those with PE, are complex medical conditions affecting approximately 12% of pregnancies, requiring specialized medical supervision and interventions to reduce the likelihood of adverse maternal and perinatal outcomes.27 These pregnancies involve medical conditions that potentially compromise maternal or fetal health, with risk factors including advanced maternal age, pre-existing medical conditions like diabetes, and pregnancy-specific complications.28 The prognosis of high-risk pregnancies is generally good when identified early and appropriately managed.29 However, challenges remain, particularly in resource-limited and conflict-stricken settings like Yemen. Factors such as socioeconomic status, access to healthcare, and maternal health conditions can impact the effectiveness of management strategies. Management of high-risk pregnancies typically involves early risk stratification, multidisciplinary care, and enhanced maternal-fetal surveillance, with growing evidence supporting structured outpatient monitoring programs in tertiary obstetric centers as a safe, cost-effective alternative to prolonged inpatient care for selected conditions.30

The burden of PE in Yemen is exacerbated by poor access to antenatal services, a lack of qualified healthcare providers, delays in seeking and receiving care, and disrupted health systems, particularly in conflict-affected governorates like Taiz. Nevertheless, there are only a few studies on PE in the country. For instance, 10.1% (174/1728) of pregnant women who delivered from May 2012 to the end of April in 2013 in the Saudi Hospital in Hajjah governorate, north of Yemen, were found to have PE/eclampsia.31 A case-control study of 206 mothers at Al-Sabeen Hospital in Sana’a identified maternal age (both young and advanced), rural residence, history of HTN or anemia, multiple pregnancies, and prior cesarean delivery as risk factors for PE.32 Two other recent hospital-based studies in Sana’a city and Al-Dhalea governorate have focused on platelet indices as early markers of PE.33,34 The ongoing conflict, deterioration of health infrastructure, and disparities in ANC coverage have likely increased the risk of PE among Yemeni women, yet current epidemiological data are limited. This lack of local evidence makes it harder for clinicians, hospital managers, and policymakers to detect high-risk pregnancies early, allocate resources effectively, and design targeted interventions.

The Republican General Teaching Hospital is one of the largest referral maternity hospitals in Taiz, with a large number of obstetric admissions. However, no studies have investigated the prevalence of PE or its associated factors among women delivering in this hospital. Therefore, the current study aimed to bridge this gap by investigating the prevalence of PE and its associated factors among pregnant women admitted for delivery at the Republican General Teaching Hospital.

Methods

Study Design, Population and Setting

A retrospective cross-sectional study was conducted to investigate PE and its associated factors at the Republican General Teaching Hospital in Taiz, which is the second largest hospital in the governorate. PE was defined as systolic blood pressure (BP) ≥140 mmHg and/or diastolic BP ≥90 mmHg after 20 weeks of gestation in the presence of proteinuria or other organ dysfunction. The study analyzed the medical records of a selected sample of women admitted for delivery at the Gynecology and Obstetrics Department from January to December 2024. Records with missing or incomplete data for key variables were excluded during data extraction.

Sample Size and Sampling Strategy

A sample size of 139 records was calculated using OpenEpi, version 3.01 (https://www.openepi.com), assuming an expected prevalence of PE of 10%,31 a 95% confidence level, and a 5% margin of error. To account for missing data, the sample size was increased to 205. A convenience sampling method was utilized, where eligible medical records were consecutively reviewed until the sample size was achieved.

Data Collection

A structured data collection sheet was developed following a thorough review of the relevant literature and in alignment with the study objectives. The collected data included demographic characteristics (age and place of residence), obstetric characteristics (parity, gravidity, gestational age (GA), multiplicity of gestation, and ANC follow-up), and medical history (chronic HTN, history of HTN, GDM, previous PE, history of abortion, and history of renal disease).

Data Analysis

Data analysis was performed using the IBM SPSS Statistics, version 24 (IBM Corp., Armonk, NY, USA). Frequencies and percentages were used to describe categorical data, while the mean and standard deviation (SD) were used for normally distributed continuous data. Pearson’s chi-square or Fisher’s exact test was used to assess the associations between PE and study variables. The odds ratios (ORs) and 95% confidence intervals (CIs) of associations were reported. A P-value of <0.05 was considered statistically significant.

Ethical Considerations

This study adhered to the Declaration of Helsinki and was approved by the Research Ethics Committee of the University of Science and Technology (USTY) in Sana’a, Yemen (Ethical clearance No.: 1447/0077/UREC/UST). Informed consent was waived due to the retrospective design of the study. Anonymity and confidentiality of all women’s data were strictly maintained, and no information was used outside the scope of this research.

Results

Demographic Obstetric Characteristics of the Study Population

The mean age of the pregnant women included in the study was 27.9±6.7 years, with the majority being younger than 30 years (59.5%) and residing in urban areas (63.4%). Regarding parity, 41.5% of women were multiparous, followed by 24.4% primiparous, 21.5% nulliparous, and 12.7% grand multiparous. For gravidity, 48.3% were multigravida, 31.7% grand multigravida, and 20% primigravida. The mean GA at admission was 38.0±3.4 weeks, with most pregnancies being below 40 weeks of gestation (82.9%). Almost all pregnancies were singleton (97.6%), with only 2.4% being twin gestations. Regarding ANC, 63.4% of women reported no ANC follow-up, whereas 36.6% had attended at least one ANC visit (Table 1).

Table 1.

Demographic and Obstetric Characteristics of the Study Population (N = 205)

Characteristics n (%)
Maternal age (years)
 Mean ± SD: 27.9±6.7
 <30 122 (59.5)
 ≥30 83 (40.5)
Place of residence
 Urban 130 (63.4)
 Rural 75 (36.6)
Parity
 Nulliparous 44 (21.5)
 Primiparous 50 (24.4)
 Multiparous 85 (41.5)
 Grand multiparous 26 (12.7)
Gravidity
 Primigravida 41 (20.0)
 Multigravida 99 (48.3)
 Grand multigravida 65 (31.7)
GA at admission (weeks)
 Mean ± SD: 38.0±3.4
 <37 35 (17.1)
 ≥37 170 (82.9)
Multiplicity of gestation
 Singleton 200 (97.6)
 Twin 5 (2.4)
Self-reported ANC follow-up
 No 130 (63.4)
 Yes 75 (36.6)

Abbreviations: SD, standard deviation; GA, gestational age; ANC, antenatal care.

Medical History of the Study Population

Table 2 shows that about one-quarter of women had a history of abortion. In addition, a small proportion had chronic HTN (2.9%) or a history of HTN (2.4%). PE in previous pregnancies was observed in 1.5% of women, while a history of GDM and renal disease was each present in 0.5% of the participants.

Table 2.

Medical History of Women Included in the Study (N = 205)

Medical History n (%)
History of abortion 51 (24.9)
Chronic HTN 6 (2.9)
History of HTN 5 (2.4)
Previous PE 3 (1.5)
History of GDM 1 (0.5)
History of renal disease 1 (0.5)

Abbreviations: HTN, hypertension; PE, preeclampsia; GDM, gestational diabetes mellitus.

Prevalence of Preeclampsia

The overall prevalence of PE among pregnant women admitted to the Gynecology and Obstetrics Department at the Republican General Teaching Hospital was 10.7% (22/205; 95% CI: 6.9–15.8).

Factors Associated with Preeclampsia

Table 3 shows that GA was significantly associated with PE among pregnant women, where the likelihood of PE was more than 10-fold higher among women who were admitted at GA <37 weeks compared to those admitted at GA ≥37 weeks (OR = 10.6; 95% CI: 4.05–27.60; P < 0.001). Although women with nulliparity (OR = 2.3, 95% CI: 0.44–11.86), twin pregnancies (OR = 2.1, 95% CI: 0.23–19.97), chronic HTN (OR = 4.5, 95% CI: 0.77–25.99), a history of HTN (OR = 2.1, 95% CI: 0.23–19.67), and previous PE (OR = 4.3, 95% CI: 0.38–49.57) had higher odds of PE compared to their counterparts, the differences were not statistically significant. In addition, PE was not significantly associated with maternal age, place of residence, gravidity, self-reported ANC follow-up, history of abortion, a history of GDM, or a history of renal disease.

Table 3.

Factors Associated with PE Among Women Admitted to the Gynecology and Obstetrics Department at the Republican General Teaching Hospital in Taiz City, Yemen (2024)

Factor N Presence of PE P-value
n (%) OR (95% CI)
Maternal age (years)
 <30 122 15 (12.3) Reference
 ≥30 83 7 (8.4) 0.7 (0.26–1.69) 0.381
Place of residence
 Urban 130 11 (8.5) Reference
 Rural 75 11 (14.7) 1.9 (0.76–4.52) 0.167
Parity
 Nulliparous 44 7 (15.9) 2.3 (0.44–11.86) 0.331
 Primiparous 50 2 (4.0) 0.5 (0.07–3.77) 0.501
 Multiparous 85 11 (12.9) 1.8 (0.37–8.62) 0.472
 Grand multiparous 26 2 (7.7) Reference
Gravidity
 Primigravida 41 6 (14.6) 1.1 (0.35–3.26) 0.910
 Multigravida 99 7 (7.1) 0.5 (0.17–1.34) 0.160
 Grand multigravida 65 9 (13.8) Reference
GA at admission (weeks)
 <37 35 13 (37.1) 10.6 (4.05–27.60) <0.001
 ≥37 170 9 (5.3) Reference
Multiplicity of gestation
 Singleton 200 21 (10.5) Reference
 Twin 5 1 (20.0) 2.1 (0.23–19.97) 0.436
ANC follow-up
 Yes 75 8 (10.7) Reference
 No 130 14 (10.8) 1.0 (0.40–2.48) 0.982
History of abortion
 No 154 19 (12.3) Reference
 Yes 51 3 (5.9) 0.4 (0.13–1.57) 0.197
Chronic HTN
 No 199 20 (10.1) Reference
 Yes 6 2 (33.3) 4.5 (0.77–25.99) 0.127
History of HTN
 No 200 21 (10.5) Reference
 Yes 5 1 (20.0) 2.1 (0.23–19.67) 0.436
Previous PE
 No 202 21 (10.4) Reference
 Yes 3 1 (33.3) 4.3 (0.38–49.57) 0.290
History of GDM
 No 204 21 (10.3) NA 0.107
 Yes 1 1 (100.0)
History of renal disease
 No 204 22 (10.8) NA 1.000
 Yes 1 0 (0.0)

Abbreviations: PE, preeclampsia; OR, odds ratio; CI, confidence interval; GA, gestational age; ANC, antenatal care; HTN, hypertension; GDM, gestational diabetes mellitus; NA, not applicable.

Discussion

To the best of our knowledge, this study is the first to investigate the prevalence and determinants of PE in Taiz City, one of Yemen’s most heavily conflict-stricken settings. It revealed a PE prevalence of 10.7% among pregnant women admitted for delivery at the Republican General Teaching Hospital in the city, which is comparable to the 10.1% reported from Hajjah Governorate in 2012–2013,31 indicating a persistently elevated burden of pre-eclampsia across diverse Yemeni settings despite geographical and temporal differences. This consistency may reflect shared underlying determinants, such as widespread poverty, limited ANC coverage, and health system fragility.

The prevalence of PE in the present study exceeds pooled global estimates of 4.4%.5 In addition, it is higher than PE prevalence reported from other Arab countries, including Lebanon (1%),12 Saudi Arabia (1.1–4.2%),9,10,13,14,16 Qatar (1.3–2.3%),12,18 Jordan (1.3–4.7%),12,15 Bahrain (1.9–2.7%),11,19 OPT (2.4%),12 and Iraq (4.4%).17 Lower rates were also reported from low- and middle-income countries, including Angola (0.9%), Niger (1.1%), China (2.2%), Mexico (7.3%), Brazil (8.2%), and northeastern Ethiopia (8.4%).35–37 However, a slightly higher PE prevalence of 12.4% was reported for pregnant women in southeastern Ethiopia.38 Differences in sample size, study design and settings, diagnostic criteria, population characteristics, and the quality of ANC services may account for these variations. The relatively higher prevalence of PE in Yemen compared to other countries may reflect disparities in maternal health infrastructure and socioeconomic conditions, such as poor nutrition, early marriage, and limited ANC follow-up.

In this study, GA <37 weeks was the only factor significantly associated with PE, being associated with more than a 10-fold increase in the likelihood of PE. This finding may be explained by the fact that early-onset PE is generally more severe and strongly linked to placental dysfunction,39 making it more likely to be detected during the earlier stages of pregnancy. Furthermore, Yemen’s limited ANC services and delayed initiation of routine visits hinder the identification of mild or late-onset cases. In line with the present finding, a large population-based case–control study in Scotland found that PE is strongly associated with preterm birth, with affected women having more than a fourfold higher likelihood of preterm deliveries.40

In this study, maternal age, place of residence, parity, gravidity, chronic HTN, history of HTN, previous PE, history of GDM, history of renal disease, and lack of ANC were not significantly associated with PE. These findings are consistent with results from Bangladesh, where no significant association was reported between classical risk factors, such as maternal age, parity, or family history of HTN, and the occurrence of PE.41 However, they contrast with findings from Ethiopia, where maternal age, parity, and history of diabetes or HTN were identified as significant predictors.36 Unlike the present study, PE was found to be significantly associated with HTN and first pregnancies among pregnant women in Jordan,15 as well as with maternal age between 26–35 years, nulliparity, previous abortion, chronic HTN, renal disease, GDM, and singleton pregnancy among women in Najaf, Iraq.17 In contrast to the present study, a large systematic review and meta-analysis of 51 studies from sub-Saharan Africa demonstrated that several maternal factors, including primiparity, prior history of PE/eclampsia, chronic HTN and absence of ANC, were significantly associated with increased risk of PE.42 Several contextual and methodological explanations may account for the lack of association between classical factors commonly cited in the literature and PE among women in the present study. In this context, the relatively small sample size and the extremely low prevalence of chronic comorbidities, such as HTN, GDM and renal disease, may reduce the statistical power to detect associations that are well-established in the literature.

The findings of this study have important policy and practice implications for maternal health in Yemen. Priority should be given to strengthening ANC, particularly early blood pressure screening and risk stratification. In settings with limited specialist care, task shifting to trained midwives and primary healthcare workers may enhance the early detection and referral of high-risk pregnancies. Establishing clear referral pathways, ensuring the availability of essential medications, and implementing standardized management protocols are feasible interventions. In conflict-affected areas such as Taiz, targeted support for referral hospitals and community-based health education may help reduce preventable maternal and neonatal complications related to PE.

This study from a major referral hospital provides valuable insights into the burden of PE in a conflict-affected setting where maternal health data are extremely limited. Its findings underline the need to strengthen ANC services and early identify pregnant women at risk of hypertensive disorders. However, we acknowledge a few limitations. First, selection bias and limited generalizability to pregnant women in the city may result from the retrospective design and convenience sampling of records. Second, the cross-sectional design of this study limits the ability to infer causal relationships between PE and the identified associated factors, and the findings therefore represent statistical associations rather than evidence of causality and should be interpreted with caution. Furthermore, underreporting and incorrect exposure classification may have been caused by inconsistent documentation in health systems impacted by conflict. On the other hand, data analysis was limited to univariate associations, as multivariable logistic regression analysis was not performed due to the relatively small number of PE cases and the very low prevalence of several key exposure variables, which could compromise the reliability of regression estimates. The lack of standardized assessments for proteinuria, laboratory indicators, and ANC quality further limited the ability to fully characterize disease severity and related risk factors. Future research is recommended using larger sample sizes and prospective multicenter designs to increase statistical power and account for population variations. Despite these limitations, the study provides preliminary data to guide national health programs and future studies on PE.

Conclusion

PE affects approximately one in ten pregnant women admitted for delivery in Taiz City, exceeding regional and global estimates. GA <37 weeks shows a significant association with PE, underscoring the need to strengthen antenatal screening, improve early detection, and enhance the management of high-risk pregnancies to reduce preventable adverse maternal and neonatal outcomes.

Acknowledgments

The authors thank the administration and staff of Republican General Teaching Hospital in Taiz for their help and support. They also thank Prof Rashad Abdul-Ghani, Faculty of Medicine and Health Sciences, Sana’a University, for his help during the preparation and revision of the manuscript.

Disclosure

The authors have no conflicts of interest associated with this study.

References

  • 1.Poon LC, Shennan A, Hyett JA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019;145(Suppl 1):1–9. doi: 10.1002/ijgo.12802 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Magee LA, Brown MA, Hall DR, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27:148–169. doi: 10.1016/j.preghy.2021.09.008 [DOI] [PubMed] [Google Scholar]
  • 3.American College of Obstetricians and Gynecologists. Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237–e260. doi: 10.1097/aog.0000000000003891 [DOI] [PubMed] [Google Scholar]
  • 4.World Health Organization. Pre-eclampsia: key facts. 2025. Available from: https://www.who.int/news-room/fact-sheets/detail/pre-eclampsia. Accessed November 14, 2025.
  • 5.Vera-Ponce VJ, Loayza-Castro JA, Ballena-Caicedo J, Zuzunaga-Montoya FE, Valladolid-Sandoval LAM, Gutierrez De Carrillo CI. Global prevalence of preeclampsia, eclampsia, and HELLP syndrome: a systematic review and meta-analysis. Front Reprod Health. 2025;7:1706009. doi: 10.3389/frph.2025.1706009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zhao X, Kong W. Global temporal trends in maternal hypertensive disorders incidence and mortality from 1990 to 2021 based on the global burden of disease study. Sci Rep. 2025;15(1):9035. doi: 10.1038/s41598-025-93673-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.World Health Organization. Make every mother and child count, in The world health report 2005. Geneva: World Health Organization; 2005. [Google Scholar]
  • 8.Hegazy A, Eid FA, Ennab F, Sverrisdóttir YB, Atiomo W, Azar AJ. Prevalence of pre-eclampsia in women in the Middle East: a scoping review. Front Public Health. 2024;12:1384964. doi: 10.3389/fpubh.2024.1384964 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Al-Ghamdi SM, Al-Harbi AS, Khalil A, El-Yahyia AR. Hypertensive disorders of pregnancy: prevalence, classification and adverse outcomes in northwestern Saudi Arabia. Ann Saudi Med. 1999;19(6):557–560. doi: 10.5144/0256-4947.1999.557 [DOI] [PubMed] [Google Scholar]
  • 10.Al-Mulhim AA, Abu-Heija A, Al-Jamma F, El-Harith E-HA. Pre-eclampsia: maternal risk factors and perinatal outcome. Fetal Diagn Ther. 2003;18(4):275–280. doi: 10.1159/000070809 [DOI] [PubMed] [Google Scholar]
  • 11.Rajab K, Essa A, Masaudi E. A hospital-based epidemiologic study of hypertensive disease in pregnancy. J Bahrain Med Soc. 2007;19:63–68. [Google Scholar]
  • 12.Abalos E, Cuesta C, Carroli G, et al. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. Bjog. 2014;121(Suppl 1):14–24. doi: 10.1111/1471-0528.12629 [DOI] [PubMed] [Google Scholar]
  • 13.Wahabi H, Fayed A, Esmaeil S, et al. Riyadh Mother and Baby Multicenter Cohort Study: the cohort profile. PLoS One. 2016;11(3):e0150297. doi: 10.1371/journal.pone.0150297 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Alalem DH, Aldukkan LB. Prevalence and associated risk factors for preeclampsia among pregnant women attending antenatal care in King Abdulaziz University Hospital in Jeddah, Saudi Arabia: a hospital-based study. Ann Int Med Den Res. 2018;4(1):ME29–ME32. [Google Scholar]
  • 15.Khader YS, Batieha A, Al-Njadat RA, Hijazi SS. Preeclampsia in Jordan: incidence, risk factors, and its associated maternal and neonatal outcomes. J Matern Fetal Neonatal Med. 2018;31(6):770–776. doi: 10.1080/14767058.2017.1297411 [DOI] [PubMed] [Google Scholar]
  • 16.Subki AH, Algethami MR, Baabdullah WM, et al. Prevalence, risk factors, and fetal and maternal outcomes of hypertensive disorders of pregnancy: a retrospective study in Western Saudi Arabia. Oman Med J. 2018;33(5):409–415. doi: 10.5001/omj.2018.75 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Rasul Aldbagh MB. Prevalence and risk factors of preeclampsia in Iraqi deliveries. Am J Sci Eng Res. 2020;3(1):2429. [Google Scholar]
  • 18.Maducolil MK, Al-Obaidly S, Olukade T, Salama H, AlQubaisi M, Al Rifai H. Pre-eclampsia: incidence, determinants, and pregnancy outcomes from maternity hospitals in Qatar: a population-based case-control study. J Matern Fetal Neonatal Med. 2022;35(25):7831–7839. doi: 10.1080/14767058.2021.1937983 [DOI] [PubMed] [Google Scholar]
  • 19.Tabassum S, AlSada A, Bahzad N, Sulaibeekh N, Qureshi A, Dayoub N. Preeclampsia and its maternal and perinatal outcomes in pregnant women managed in Bahrain’s Tertiary Care Hospital. Cureus. 2022;14(5):e24637. doi: 10.7759/cureus.24637 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Al Duraihimh H, Ghamdi G, Moussa D, et al. Outcome of 234 pregnancies in 140 renal transplant recipients from five Middle Eastern countries. Transplantation. 2008;85(6):840–843. doi: 10.1097/TP.0b013e318166ac45 [DOI] [PubMed] [Google Scholar]
  • 21.English FA, Kenny LC, McCarthy FP. Risk factors and effective management of preeclampsia. Integr Blood Press Control. 2015;8:7–12. doi: 10.2147/ibpc.s50641 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Weissgerber TL, Mudd LM. Preeclampsia and diabetes. Curr Diab Rep. 2015;15(3):9. doi: 10.1007/s11892-015-0579-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Bartsch E, Medcalf KE, Park AL, Ray JG. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016;353:i1753. doi: 10.1136/bmj.i1753 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Cho GJ, Park JH, Shin SA, Oh MJ, Seo HS. Metabolic syndrome in the non-pregnant state is associated with the development of preeclampsia. Int J Cardiol. 2016;203:982–986. doi: 10.1016/j.ijcard.2015.11.109 [DOI] [PubMed] [Google Scholar]
  • 25.Mrema D, Lie RT, Østbye T, Mahande MJ, Daltveit AK. The association between pre pregnancy body mass index and risk of preeclampsia: a registry based study from Tanzania. BMC Pregnancy Childbirth. 2018;18(1):56. doi: 10.1186/s12884-018-1687-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Atamamen TF, Naing NN, Oyetunji JA, Wan-Arfah N. Systematic literature review on the neonatal outcome of preeclampsia. Pan Afr Med J. 2022;41:82. doi: 10.11604/pamj.2022.41.82.31413 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Coco L, Giannone TT, Zarbo G. Management of high-risk pregnancy. Minerva Ginecol. 2014;66(4):383–389. [PubMed] [Google Scholar]
  • 28.Sokou R, Lianou A, Lampridou M, et al. Neonates at risk: understanding the impact of high-risk pregnancies on neonatal health. Medicina. 2025;61(6):1077. doi: 10.3390/medicina61061077 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Bhagat P, Kaur J. Prenatal prognostics: validating high-risk pregnancy predictions for maternal and perinatal outcomes. J Educ Health Promot. 2025;14:387. doi: 10.4103/jehp.jehp_1684_24 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Choi-Klier JI, Masters SM, Lewis DS, Eswaran H, Manning N, Magann EF. Outpatient monitoring of high risks pregnancies: an update of management in a tertiary obstetric center and review of the literature. Med Res Arch. 2024;12:11. doi: 10.18103/mra.v12i12.6086 [DOI] [Google Scholar]
  • 31.Al-Rukeimi AA, Al-Haddad A, Adam I. Risk factors for pre-eclampsia, eclampsia, and associated adverse outcomes in Hajjah, Yemen. Int J Gynaecol Obstet. 2014;127(1):91–92. doi: 10.1016/j.ijgo.2014.06.007 [DOI] [PubMed] [Google Scholar]
  • 32.Al-Tairi ANQ, Isa ZM, Ghazi HF. Risk factors of preeclampsia: a case control study among mothers in Sana’a, Yemen. J Public Health. 2017;25(6):573–580. doi: 10.1007/s10389-017-0825-0 [DOI] [Google Scholar]
  • 33.AL-Gunied ASAB, Salem AK, Allow AK, Al-Shamahy HA. Evaluation of the complete blood count parameters in pregnant women presenting with preeclampsia in Al-Gomhori Hospital Sana’a, Yemen. Sana’a Univ J Med Health Sci. 2025;19(2):181–185. doi: 10.59628/jchm.v19i2.1636 [DOI] [Google Scholar]
  • 34.Ali NT. Platelet indices: a low-cost early warning system for preeclampsia in Yemen’s fragile healthcare settings. Yemeni J Med Sci. 2025;19(6). doi: 10.20428/yjms.v19i6.2929 [DOI] [Google Scholar]
  • 35.Bilano VL, Ota E, Ganchimeg T, Mori R, Souza JP. Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: a WHO secondary analysis. PLoS One. 2014;9(3):e91198. doi: 10.1371/journal.pone.0091198 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Tessema GA, Tekeste A, Ayele TA. Preeclampsia and associated factors among pregnant women attending antenatal care in Dessie referral hospital, Northeast Ethiopia: a hospital-based study. BMC Pregnancy Childbirth. 2015;15:73. doi: 10.1186/s12884-015-0502-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Yang Y, Le Ray I, Zhu J, Zhang J, Hua J, Reilly M. Preeclampsia prevalence, risk factors, and pregnancy outcomes in Sweden and China. JAMA Network Open. 2021;4(5):e218401. doi: 10.1001/jamanetworkopen.2021.8401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Belay AS, Wudad T. Prevalence and associated factors of pre-eclampsia among pregnant women attending anti-natal care at Mettu Karl referal hospital, Ethiopia: cross-sectional study. Clin Hypertens. 2019;25:14. doi: 10.1186/s40885-019-0120-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Herzog EM, Eggink AJ, Reijnierse A, et al. Impact of early- and late-onset preeclampsia on features of placental and newborn vascular health. Placenta. 2017;49:72–79. doi: 10.1016/j.placenta.2016.11.014 [DOI] [PubMed] [Google Scholar]
  • 40.Davies EL, Bell JS, Bhattacharya S. Preeclampsia and preterm delivery: a population-based case-control study. Hypertens Pregnancy. 2016;35(4):510–519. doi: 10.1080/10641955.2016.1190846 [DOI] [PubMed] [Google Scholar]
  • 41.Mou AD, Barman Z, Hasan M, et al. Prevalence of preeclampsia and the associated risk factors among pregnant women in Bangladesh. Sci Rep. 2021;11(1):21339. doi: 10.1038/s41598-021-00839-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Meazaw MW, Chojenta C, Muluneh MD, Loxton D. Systematic and meta-analysis of factors associated with preeclampsia and eclampsia in sub-Saharan Africa. PLoS One. 2020;15(8):e0237600. doi: 10.1371/journal.pone.0237600 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Women's Health are provided here courtesy of Dove Press

RESOURCES